Literature DB >> 2857963

Efficacy of imipenem in experimental Legionnaires' disease.

R B Fitzgeorge, D H Gibson, R I Jepras, A Baskerville.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2857963     DOI： 10.1016/s0140-6736(85)92164-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  In vitro extracellular and intracellular activities of clavulanic acid and those of piperacillin and ceftriaxone alone and in combination with tazobactam against clinical isolates of Legionella species.

Authors:  P H Edelstein; M A Edelstein
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

Review 2.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

Review 3.  Treatment of Legionnaires' disease. Current recommendations.

Authors:  J Roig; A Carreres; C Domingo
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

4.  Comparative in vitro activity of CGP 31608, a new penem antibiotic.

Authors:  G M Eliopoulos; C Wennersten; E Reiszner; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

5.  Effect of quinolones and other antimicrobial agents on cell-associated Legionella pneumophila.

Authors:  D Havlichek; L Saravolatz; D Pohlod
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.